Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
5
×
life sciences
national blog main
novartis
5
×
national
national top stories
san francisco top stories
biogen
boston blog main
boston top stories
eli lilly
fda
gene therapy
indiana blog main
indiana top stories
new york top stories
roche
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
celgene
clinical trials
detroit blog main
detroit top stories
drug prices
europe top stories
ipo
johnson & johnson
new york blog main
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
spinal muscular atrophy
What
fda
drug
therapy
bio
gene
latest
new
roundup
address
alzheimer’s
approval
approved
approves
atrophy
august
biotech
blueprint
busy
cancer
carries
certain
chemistry
cmc
companies
consistent
controls
daily
days
decisions
designed
devices
different
drugs
ensure
evrysdi
fail
friday
genetic
green
home
Language
unset
Current search:
genentech
×
novartis
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More